GFACX
Price
$74.18
Change
-$1.66 (-2.19%)
Updated
Nov 13 closing price
Net Assets
340.4B
KLCSX
Price
$22.32
Change
-$0.49 (-2.15%)
Updated
Nov 13 closing price
Net Assets
1.27B
Interact to see
Advertisement

GFACX vs KLCSX

Header iconGFACX vs KLCSX Comparison
Open Charts GFACX vs KLCSXBanner chart's image
American Funds Growth Fund of Amer C
Price$74.18
Change-$1.66 (-2.19%)
VolumeN/A
Net Assets340.4B
Federated Hermes Kaufmann Large Cap R6
Price$22.32
Change-$0.49 (-2.15%)
VolumeN/A
Net Assets1.27B
GFACX vs KLCSX Comparison Chart in %
View a ticker or compare two or three
VS
GFACX vs. KLCSX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a Buy and KLCSX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 340B vs. KLCSX (1.28B). GFACX (0.00) and KLCSX (0.00) have matching dividends . GFACX was incepted earlier than KLCSX: GFACX (25 years) vs KLCSX (12 years). GFACX (1.36) is less costly to investors than KLCSX (0.87). GFACX is a more actively managed with annual turnover of: 25.00 vs. KLCSX (18.00). KLCSX has a lower initial minimum investment than GFACX: KLCSX (0) vs GFACX (250). GFACX annual gain was more profitable for investors over the last year : 4.61 vs. KLCSX (-12.95). GFACX return over 5 years is better than : 27.87 vs. KLCSX (-36.98).
GFACXKLCSXGFACX / KLCSX
Total Expense Ratio1.360.78174%
Annual Report Gross Expense Ratio1.360.87156%
Fund Existence25 years12 years-
Gain YTD16.34319.29485%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets340B1.28B26,667%
Annual Yield % from dividends0.000.00-
Returns for 1 year4.61-12.95-36%
Returns for 3 years56.17-13.59-413%
Returns for 5 years27.87-36.98-75%
Returns for 10 years75.7819.10397%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BAX18.70N/A
N/A
Baxter International
OFG40.72-0.03
-0.07%
OFG Bancorp
CVGW21.90-0.23
-1.04%
Calavo Growers
FBIOP6.53-0.27
-3.97%
Fortress Biotech
ACRV2.07-0.21
-9.21%
Acrivon Therapeutics